References
- Elena P, Gaetano V, Antonio M. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators[J]. Nature reviews. Gastroenterol Hepatol. 2019 Mar; 16(3): 160–174.
- Mundi MS, Velapati S, Patel J, et al. Evolution of NAFLD and Its Management. Nutr Clin Pract. 2020 Feb;35(1):72–84.
- Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11–20.
- Ye H, Li Q, Zhang Z, et al. Effect of a novel potential probiotic Lactobacillus paracasei Jlus66 isolated from fermented milk on nonalcoholic fatty liver in rats. Food Funct. 2017 Dec 13;8(12):4539–4546.
- Zhao Z, Wang C, Zhang L, et al. Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway. Appl Microbiol Biotechnol. 2019 Jul;103(14):5843–5850.
- Yao F, Jia R, Huang H, et al. Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease. Arch Med Sci. 2019 Sep;15(5):1336–1344.
- Marshall JC. The gut as a potential trigger of exercise-induced inflammatory responses. Can J Physiol Pharmacol. 1998;76(5):479–484.
- Li D, Zheng J, Hu Y, et al. Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats. Pharmacogn Mag. 2017 Oct-Dec;13(52):677–682.
- Chen J, Vitetta L. Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. Int J Mol Sci. 2020 Jul 23;21(15):5214.
- Chen M, Guo WL, Li QY, et al. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet. Food Funct. 2020 Apr 30;11(4):3316–3331.
- Liang Z, Chen X, Shi J, et al. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Chin Med. 2021 Jan 11;16(1):9.
- Wang H, Tao Y, Li Y, et al. Application of ultrasonication at different microbial growth stages during apple juice fermentation by Lactobacillus plantarum: investigation on the metabolic response. Ultrason Sonochem. 2021 May;73:105486.
- Peng W, Meng D, Yue T, et al. Effect of the apple cultivar on cloudy apple juice fermented by a mixture of Lactobacillus acidophilus, Lactobacillus plantarum, and Lactobacillus fermentum. Food Chem. 2021 Mar;340(340):127922.
- Lavekar AS, Raje DV, Manohar T, et al. Role of probiotics in the treatment of nonalcoholic fatty liver disease: a meta-analysis. Euroasian J Hepatogastroenterol. 2017 Jul-Dec;7(2):130–137.
- Kobyliak N, Abenavoli L, Falalyeyeva T, et al. Efficacy of probiotics and smectite in rats with non-alcoholic fatty liver disease. Ann Hepatol. 2018 January-February;17(1):153–161.
- Meroni M, Longo M, Dongiovanni P. The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies. Nutrients. 2019 Nov 4;11(11):2642.
- Tohma YA, Onalan G, Esin S, et al. Are there any predictors of endometrial premalignancy/malignancy within endometrial polyps in infertile patients? Gynecol Obstet Invest. 2019;84(5):512–518.
- Wang W, Xu AL, Li ZC, et al. Combination of probiotics and salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice. Diabetes Metab J. 2020 Apr;44(2):336–348.
- Chen YT, Lin YC, Lin JS, et al. Sugary kefir strain Lactobacillus mali APS1 ameliorated hepatic steatosis by regulation of SIRT-1/Nrf-2 and gut microbiota in rats. Mol Nutr Food Res. 2018 Apr;62(8):e1700903.
- Kim JC, Jeon JY, Yang WS, et al. Combined amelioration of ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean red Ginseng and probiotic Lactobacillus on non-alcoholic fatty liver disease. Curr Pharm Biotechnol. 2019;20(3):222–231.
- Park EJ, Lee YS, Kim SM, et al. Beneficial effects of Lactobacillus plantarum strains on non-alcoholic fatty liver disease in high fat/high fructose diet-fed rats. Nutrients. 2020 Feb 20;12(2):542.
- Mu J, Tan F, Zhou X, et al. Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. Food Funct. 2020 Oct 21;11(10):8707–8723.
- Nobili V, Putignani L, Mosca A, et al. Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? Arch Med Sci. 2018 Jan;1(1):81–87.
- Azarang A, Farshad O, Ommati MM, et al. Protective role of probiotic supplements in hepatic steatosis: a rat model study. Biomed Res Int. 2020 Nov;6(2020):5487659.
- Xie C, Halegoua-demarzio D. Role of Probiotics in Non-alcoholic Fatty Liver Disease: does gut microbiota matter? Nutrients. 2019 Nov 19;11(11):2837.
- Xiao H, Jiang J, Xie Y, et al. Colon hydrotherapy plus Traditional Chinese Medicine to treat non-alcoholic fatty liver disease: a pilot study. J Tradit Chin Med. 2017 Jun;37(3):393–396.